Suven Life Sciences per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
−₹14.89−₹12.13−₹7.37−₹4.82−₹6.63
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−₹14.89−₹12.13−₹7.37−₹4.82−₹6.63
₹22.43₹22.43₹5.04₹12.38₹17.21
₹0.33₹0.27₹0.31₹0.54₹0.62
—−₹11.44−₹7.06−₹3.79−₹9.53
−₹11.64−₹11.64−₹8.77−₹3.90−₹9.67
26.426.421.821.821.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SUVEN₹264.20

Suven Life Sciences Limited

· Pharma & Health
₹ CrorePeersVIMTALABSTAKEMcap ₹6,967 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS-6.63-4.82-7.37-12.13-14.89
Diluted EPS-6.63-4.82-7.37-12.13-14.89
Book Value per Share17.2112.385.0422.4322.43
Revenue per Share0.620.540.310.270.33
Cash Flow per Share-9.53-3.79-7.06-11.44—
Free Cash Flow per Share-9.67-3.90-8.77-11.64-11.64
Shares Outstanding (cr)21.821.821.826.426.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.